Delivery Order SPE2DB25D3005-SPE2DB25FQCTC

Award Date 2/21/25
Potential Completion Date 2/24/25
Potential Value $6.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Synthroid 25 MCG tablets in 1,000 count packages to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies. This is a firm fixed-price delivery order contract with a ceiling value of $1,462.38 and a completion date of May 14, 2024. The contract is not a set-aside award....
This federal contract award, valued at $1,679.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award covers the delivery of Synthroid 50 MCG tablets, a medication used to treat hypothyroidism. The contract has an ultimate completion date of December 5, 2024 and is structured as a firm fixed-price delivery order. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,080.12 firm fixed-price delivery order is for the supply of Synthroid 150 MCG Tablets in quantities of 1,000. The contract has an ultimate completion date of July 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,249.09, is for the delivery of Synthroid 50 MCG tablets. It is a firm fixed-price delivery order contract with a completion date of May 24, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,795,652 Synthroid 50 MCG tablets. The $1,049.64 Firm Fixed Price Delivery Order was issued by the Defense Logistics Agency (DLA) Troop Support Medical under their $999,999,999.00 Indefinite Delivery Contract (IDC) to provide a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense (DoD) facilities worldwide. Amerisourcebergen, a large...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $4,854.71 for Synthroid 50 mcg tablets. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency that supports the Department of Defense. The contract has a completion date of February 6, 2024 and uses a firm fixed price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 1,000 units of Synthroid 25 mcg tablets. The $2,729 firm fixed-price delivery order has an ultimate completion date of October 17, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
This federal contract award, with ID SPE2DB20D1100|SPE2DB24FA5G7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SYNTHROID 200 MCG TABLET 1000S, with a ceiling value of $2,375.11 and a period of performance through March 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,322.90 firm fixed price delivery order is for the provision of 4,566,660 units of SYNTHROID 75 MCG TABLET 1000S. The contract has a completion date of December 10, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $13,671.28, is for the delivery of 4,565,021,765 units of the drug Synthroid (levothyroxine sodium) 137 mcg tablets. The contract has a ceiling value of $13,671.28 and runs through June 28, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999 that serves...
  • SPE2DB25D3005
    Indefinite Delivery Contract
  • SPE2DB25D3005-SPE2DB25FQCTC
    Delivery Order

This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Synthroid 50 MCG tablets. The contract, awarded by the Defense Logistics Agency (DLA), has a ceiling value of $6,077.15 and runs through February 2025. It is a firm fixed-price delivery order contract type. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have any set-aside designation, indicating open competition.

Generated 5/23/25, 10:05 AM